MeSH tree: C14.240.850
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a cell surface receptor protein called TIE2 as the missing link between two key signaling pathways that drive the growth of ...
Mar 27, 2026
0
3
The cost of emergency dialysis is estimated to be eight times that of in-center dialysis. A new study reveals that a transitional dialysis program piloted in Travis County (Austin, Texas) resulted in a significant decrease ...
Nov 8, 2025
0
17
Sound waves at frequencies above the threshold for human hearing are routinely used in medical care. Also known as ultrasound, these sound waves can help clinicians diagnose and monitor disease, and can also provide first ...
Oct 15, 2025
0
13
To undergo kidney dialysis, doctors must first surgically create an access route—an arteriovenous fistula—usually in an arm, a conduit that will accommodate hemodialysis treatments. It is a routine outpatient procedure performed ...
More than 4 million people worldwide have end-stage kidney disease that requires hemodialysis, a treatment in which a machine filters waste from the blood. Hemodialysis is a precursor to kidney transplant. To prepare for ...
Sep 24, 2025
0
16
System-based disparities in predialysis access to nephrology care contribute to disparities in the likelihood of having a mature, usable arteriovenous access for starting hemodialysis (incident vascular access) among Hispanic ...
Sep 5, 2025
0
18
A Boston Children's Hospital study uncovers how fetal magnetic resonance imaging (MRI) could be a game-changer in predicting outcomes for infants born with vein of Galen malformations (VOGMs).
Apr 8, 2025
0
8
During development, cells grow, expand, and migrate to generate tissues and organs in a highly controlled manner. Many intracellular pathways—series of signaling cascades within a cell—regulate these actions to avoid non-programmed ...
Mar 31, 2025
0
12
Children with cavernous malformations face unique treatment challenges due to factors such as the malformation's location, size, risk of bleeding, and the complexities of pediatric tissue development. To address these issues ...
Nov 14, 2024
0
13
A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that impacts more than one in 5,000 people worldwide.
Sep 18, 2024
0
42
